Edition:
United Kingdom

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

153.11USD
13 Jul 2018
Change (% chg)

$-0.21 (-0.14%)
Prev Close
$153.32
Open
$153.47
Day's High
$154.27
Day's Low
$152.84
Volume
50,426
Avg. Vol
74,319
52-wk High
$166.47
52-wk Low
$113.05

Latest Key Developments (Source: Significant Developments)

Bio-Techne To Acquire Exosome Diagnostics Inc
Monday, 25 Jun 2018 

June 25 (Reuters) - Bio-Techne Corp ::BIO-TECHNE TO ACQUIRE EXOSOME DIAGNOSTICS, INC..BIO-TECHNE CORP - DEAL FOR $250 MILLION IN CASH PLUS CONTINGENT CONSIDERATION OF UP TO $325 MILLION DUE UPON ACHIEVEMENT OF CERTAIN FUTURE MILESTONES.BIO-TECHNE CORP - DEAL TO BE FINANCED USING CASH ON HAND & A REVOLVING LINE OF CREDIT FACILITY THAT CO EXPECTS TO OBTAIN PRIOR TO CLOSING OF DEAL.  Full Article

Bio-Techne Acquires Atlanta Biologicals Inc
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Bio-Techne Corp ::BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC.BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​.BIO-TECHNE - DEAL EXPECTED TO BE SLIGHTLY ACCRETIVE TO ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018.  Full Article

Bio-Techne releases Q1 adjusted earnings per share $0.90
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Bio-Techne Corp :Bio-Techne releases first quarter fiscal 2018 results.Q1 adjusted earnings per share $0.90.Q1 GAAP earnings per share $0.42.Q1 sales $144.6 million versus I/B/E/S view $142.9 million.Q1 earnings per share view $0.88 -- Thomson Reuters I/B/E/S.  Full Article

Bio-Techne posts Q4 adjusted EPS of $0.92
Wednesday, 17 Aug 2016 

Bio-techne Corp : Q4 adjusted earnings per share $0.92 . Q4 earnings per share view $0.96 -- Thomson Reuters I/B/E/S . Techne releases fourth quarter fiscal 2016 results . Q4 gaap earnings per share $0.69 . Q4 sales $134.8 million versus i/b/e/s view $129.2 million .Techne - in q4, incurred transactional foreign exchange losses due to fall of british pound and european commercial operations being based in uk.  Full Article

Bio-Techne signs credit agreement
Tuesday, 2 Aug 2016 

Bio-Techne Corp : On July 28, 2016, Bio-Techne Corp entered into a credit agreement - sec filing . Credit agreement matures on July 28, 2021 . Credit agreement provides for revolving credit facility of $400 million, which can be increased by additional $200 million subject to conditions .At closing on July 28, co drew $343.5 million on credit agreement in relation to closing of merger and for payment of outstanding debt.  Full Article

BRIEF-Bio-Techne Q3 GAAP Earnings Per Share $0.52

* Q3 EARNINGS PER SHARE VIEW $1.14 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: